Ellen Bork
Impact in
- Oncology top 10%
- Lung Cancer Research Studies
- Peptidase Inhibition and Analysis
-
- Occupational and environmental lung diseases
- Oral health in cancer treatment
- Lung Cancer Treatments and Mutations
Papers in
- Oncology 8
- Lung Cancer Research Studies 6
-
- Neuroendocrine Tumor Research Advances 7
- Co-authors
- Mark Alexander Berner-Hansen (6 shared papers)P Dombernowsky (5 shared papers)Hansen Hh (2 shared papers)Jens Benn Sørensen (2 shared papers)Heine Høi Hansen (2 shared papers)Lars Damstrup (1 shared paper)Torben Skovsgaard (1 shared paper)H.H. Hansen (2 shared papers)
- Journals
- Journal of Clinical Oncology (4 papers)Cancer (2 papers)Lung Cancer (1 paper)Clinical Endocrinology (1 paper)Recent results in cancer research (1 paper)
- Partner nations
- DenmarkBelgiumNetherlands
In The Last Decade
Ellen Bork
17 papers receiving 459 citations
Peers
Comparison fields: 5 of 68
- Oncology 257
- Pulmonary and Respiratory Medicine 235
- Otorhinolaryngology 29
- Epidemiology 101
- Neurology 32
Countries citing papers authored by Ellen Bork
This map shows the geographic impact of Ellen Bork's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Bork with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Bork more than expected).
Fields of papers citing papers by Ellen Bork
This network shows the impact of papers produced by Ellen Bork. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Bork. The network helps show where Ellen Bork may publish in the future.
Co-authors
The 25 scholars most cited alongside Ellen Bork, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 76 | |
| 2 | Randomized trial of doxorubicin versus cyclophosphamide in diffuse malignant pleural mesothelioma. | 1985 | 73 |
| 3 | 1986 | 69 | |
| 4 | 1991 | 45 | |
| 5 | 1987 | 39 | |
| 6 | 1988 | 39 | |
| 7 | 1989 | 33 | |
| 8 | 1989 | 24 | |
| 9 | Phase II study of teniposide in small cell carcinoma of the lung. | 1984 | 24 |
| 10 | 1988 | 21 | |
| 11 | 1987 | 17 | |
| 12 | 1985 | 11 | |
| 13 | 1989 | 10 | |
| 14 | 1993 | 9 | |
| 15 | 1997 | 5 | |
| 16 | [Possible incompatibility of deep radiotherapy and high-dose adriamycin or cyclophosphamide therapy in advanced genital tumors of the female]. | 1976 | 1 |
| 17 | Severe hyponatremia following simultaneous administration of aminoglutethimide and diuretics. | 1986 | 1 |
About Ellen Bork
Ellen Bork is a scholar working on Oncology, Epidemiology, Pulmonary and Respiratory Medicine, Molecular Biology and Neurology, having authored 17 papers that have together received 497 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (7 papers), Lung Cancer Research Studies (6 papers), Cancer therapeutics and mechanisms (4 papers), Biochemical and Molecular Research (3 papers), Neuroblastoma Research and Treatments (2 papers), Electrolyte and hormonal disorders (2 papers), Neuropeptides and Animal Physiology (2 papers) and Oral health in cancer treatment (2 papers). The work is most often cited by research in Oncology (257 citations), Pulmonary and Respiratory Medicine (235 citations), Otorhinolaryngology (29 citations), Epidemiology (101 citations) and Neurology (32 citations). Ellen Bork has collaborated with scholars based in Denmark, Belgium and Netherlands. Frequent co-authors include Mark Alexander Berner-Hansen, P Dombernowsky, Hansen Hh, Jens Benn Sørensen, Heine Høi Hansen, Lars Damstrup, Torben Skovsgaard, H.H. Hansen, Jens Juul Holst and Anders Gersel Pedersen. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Lung Cancer, Clinical Endocrinology and Recent results in cancer research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.